Concepedia

Lavanya Kondiparthi

LK

7

Publications

1K

Citations

7

H-Index

2021

Active since

Affiliations

Eon Corporation (United States)(Current)

The University of Texas Health Science Center at Houston

The University of Texas MD Anderson Cancer Center

Baylor College of Medicine

Franklin Institute

Lavanya Kondiparthi is an author at Eon Corporation (United States) specializing in medicine, signal transduction, and cell death.

ORCID

Top concepts

Publications per year

2021–2024

7

Publications

7

A targetable CoQ-FSP1 axis drives ferroptosis- and radiation-resistance in KEAP1 inactive lung cancers

Pranavi Koppula, Guang Lei, Yilei Zhang et al. · Nature Communications · 2022 · 423 citations · Full text

SLC7A11 expression level dictates differential responses to oxidative stress in cancer cells

Yuelong Yan, Hongqi Teng, Qinglei Hang et al. · Nature Communications · 2023 · 267 citations · Full text

A ferroptosis defense mechanism mediated by glycerol-3-phosphate dehydrogenase 2 in mitochondria

Shiqi Wu, Chao Mao, Lavanya Kondiparthi et al. · Proceedings of the National Academy of Sciences · 2022 · 110 citations · Full text

Cell cycle arrest induces lipid droplet formation and confers ferroptosis resistance

Hyemin Lee, Amber D. Horbath, Lavanya Kondiparthi et al. · Nature Communications · 2024 · 99 citations · Full text

KEAP1 deficiency drives glucose dependency and sensitizes lung cancer cells and tumors to GLUT inhibition

Pranavi Koppula, Kellen Olszewski, Yilei Zhang et al. · iScience · 2021 · 60 citations · Full text

Rows per page

1–5 of 7